COMP <GO>
EYPT vs HBIO // RSI-14 & 200D SMA MOMENTUM
EyePoint Inc. (NASDAQ) VS. Harvard Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: EYPT 0
— HBIO 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: HBIO
LAST: $0.38 (+0.69%) • MKT CAP: $32.8M
rsi-technicals
15.7
LAST: $8.80 (+4.51%) • MKT CAP: $40.1M
rsi-technicals
68.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EYPT VS. HBIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EYPT | HBIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 57.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 13.66% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -56.10% | -3.90 | HBIO | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -27.50% | -8.10% | -19.40 | HBIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 5/9 | -4.00 | HBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 15.7 | 68.8 | -53.13 | HBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $32.8M | $40.1M | -$7.3M | HBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EYPT REV | HBIO REV | EYPT GROSS % | HBIO GROSS % | EYPT FCF | HBIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $31.4M | $86.5M | — | 57.7% | -$243.4M | $5.5M |
| FY 2024 | $43.3M | $94.1M | — | 58.2% | -$130.3M | -$1.2M |
| FY 2023 | $46.0M | $112.3M | — | — | $1.9M | $14.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EYPT // BETA —
HBIO // BETA —